Research programme: cell-based lung disorder therapeutics - Northern TherapeuticsAlternative Names: Bone marrow derived alveolar progenitor cells - Northern Therapeutics; Cell-based gene therapy - Northern Therapeutics; Cell-based regenerative therapy - Northern therapeutics
Latest Information Update: 02 Nov 2016
At a glance
- Originator Northern Therapeutics
- Class Cell therapies; Gene therapies
- Mechanism of Action Cell replacements; Gene transference
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Adult respiratory distress syndrome; Cystic fibrosis; Emphysema